US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,482 | -3,828 | -2,897 | -2,472 | -2,070 |
| Depreciation Amortization | 305 | 466 | 332 | 92 | 6 |
| Accounts receivable | -44 | -98 | -15 | -35 | 13 |
| Accounts payable and accrued liabilities | 469 | 519 | 305 | 206 | 11 |
| Other Working Capital | 1,711 | 935 | 777 | 311 | 1,155 |
| Other Operating Activity | 2,271 | 3,031 | 2,283 | 2,168 | 998 |
| Operating Cash Flow | $1,231 | $1,026 | $786 | $268 | $112 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 399 | 399 | 400 | 400 | -12 |
| Purchase Of Investment | 225 | 190 | 140 | 80 | 175 |
| Other Investing Activity | 100 | 100 | 100 | 100 | 0 |
| Investing Cash Flow | $724 | $689 | $640 | $580 | $163 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | N/A | N/A | 15 |
| Debt Issued | 155 | 155 | 52 | 52 | 523 |
| Debt Repayment | -1,139 | -1,084 | -817 | -458 | -267 |
| Common Stock Issued | 275 | 250 | 250 | 0 | 60 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -8 |
| Other Financing Activity | -530 | -350 | -252 | -94 | -386 |
| Financing Cash Flow | $-1,239 | $-1,029 | $-767 | $-500 | $-63 |
| Beginning Cash Position | 271 | 271 | 271 | 271 | 58 |
| End Cash Position | 987 | 957 | 930 | 619 | 271 |
| Net Cash Flow | $716 | $686 | $659 | $348 | $212 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,231 | 1,026 | 786 | 268 | 112 |
| Capital Expenditure | -1 | -1 | N/A | N/A | -13 |
| Free Cash Flow | 1,230 | 1,025 | 786 | 268 | 100 |